Vitamin Shoppe INC (VSI) Holder Shah Capital Management Has Upped Its Position

April 17, 2018 - By Adrian Erickson

Vitamin Shoppe, Inc. (NYSE:VSI) Logo

Himanshu H. Shah increased its stake in Vitamin Shoppe Inc (VSI) by 157.87% based on its latest 2017Q4 regulatory filing with the SEC. Shah Capital Management bought 2.04 million shares as the company’s stock rose 6.10% while stock markets declined. The hedge fund run by Himanshu H. Shah held 3.33 million shares of the consumer non-durables company at the end of 2017Q4, valued at $14.65 million, up from 1.29M at the end of the previous reported quarter. Shah Capital Management who had been investing in Vitamin Shoppe Inc for a number of months, seems to be bullish on the $111.33 million market cap company. The stock increased 4.55% or $0.2 during the last trading session, reaching $4.6. About 224,406 shares traded. Vitamin Shoppe, Inc. (NYSE:VSI) has declined 77.86% since April 17, 2017 and is downtrending. It has underperformed by 89.41% the S&P500.

Shah Capital Management, which manages about $220.22 million and $217.09M US Long portfolio, decreased its stake in China Xiniya Fashion Ltd by 1.91M shares to 957,263 shares, valued at $4.97 million in 2017Q4, according to the filing.

Vitamin Shoppe, Inc. (NYSE:VSI) Ratings Coverage

Among 2 analysts covering Vitamin Shoppe (NYSE:VSI), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Vitamin Shoppe had 3 analyst reports since November 9, 2017 according to SRatingsIntel. Morgan Stanley maintained Vitamin Shoppe, Inc. (NYSE:VSI) rating on Thursday, November 9. Morgan Stanley has “Equal-Weight” rating and $4 target. Barclays Capital maintained Vitamin Shoppe, Inc. (NYSE:VSI) rating on Thursday, November 9. Barclays Capital has “Equal-Weight” rating and $3 target. Morgan Stanley maintained Vitamin Shoppe, Inc. (NYSE:VSI) on Wednesday, February 28 with “Equal-Weight” rating.

Vitamin Shoppe, Inc. (NYSE:VSI) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: